Survodutide vs Tirzepatide: Two Ways to Build a Dual Agonist
Both survodutide and tirzepatide are dual agonists — but they target entirely different receptor pairs. This mechanistic comparison breaks down what each architectural choice means for energy expenditure, gastric emptying, and hepatic signaling in research models.